Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
React to this article
Latest news
Date Title
04:07a TRANSASIA AIRWAYS : TAIWAN - TransAsia pilot 'shut down wrong engine' before crash
04:07a PRIMARY HEALTH PROPERTIES : Buys Macclesfield Site for GBP2.5 Million
04:07a NORTH RIVER RESOURCES : Appoints James Beams Chief Executive, Executive Director
04:06a STARWOOD HOTELS & RESORTS WORLDWIDE : on-track for its environmental goals 2020
04:06a RITE AID : BRIEF: Somersworth police searching for armed robbery suspect
04:06a AMEC FOSTER WHEELER : appoints new MENA president
04:06a NATIONWIDE CCDS CORE CAPITAL DEFERRED SHS MIN 250 CCDS : U.K. Nationwide HPI -0.2% vs. 0.5% forecast
04:06a DRAGON OIL : ENOC presses ahead with Dragon Oil acqusition
04:06a ZAMIL INDUSTRIAL INVESTMENT : Steel wins $5.4m turnkey deal in Jeddah
04:06a INTERNET OF THINGS : UAE heads IoT expert group at ITU
Latest news
Advertisement
Hot News 
REGENCY MINES : Issue of Equity and TVR
THERACLION : First Echopulse Reference Site in Asia: The University of Hong Kong Awards Tender to Theraclion
LOOSER : Press release - Quality assurance of the highest standard
SPECTRA SYSTEMS : Wins 9-Year Deal With Chinese Secure Documents Firm
CREDIT SUISSE : Hello Zurich: Tidjane shakes up Credit Suisse on his first day
Most Read News
07/01 U.S. sues to stop Electrolux acquiring GE's appliance business
07/01 PayPal to buy digital money transfer provider Xoom
07/01 Peak Venture Group Adopts the BitShares Network
07/01 Affinity, Carlyle among four shortlisted for Tesco South Korea unit sale - report
07/01DJChina Shares Tank as Beijing's Moves to Spur Buying Fall Short
Most recommended articles
04:00aDJLONDON MARKETS : FTSE 100 Wavers, But Dixons Carphone Climbs
04:00a EUR/USD to Eye 1.1000 Support on Strong U.S. Non-Farm Payrolls (NFP)
03:34a Euro zone inflationary pressures at four-year high - ECRI
03:34aDJErgomed Appoints Andrew Mackie as Chief Business Officer
03:31a RBS refers clients to Paribas for transaction services